Faculty Articles
Title
Vortioxetine (Brintellix): A New Serotonergic Antidepressant
Publication Title
P&T (Pharmacy & Therapeutics)
Volume
40
Issue
1
Publication Date / Copyright Date
1-1-2015
First Page
36
Last Page
40
Publisher
MediMedia
Abstract
Major depressive disorder (MDD) is a medical illness that affects how people feel, think, and behave, causing persistent feelings of sadness and loss of interest in previously enjoyed activity.1 Major depression frequently goes unrecognized and untreated and may foster tragic consequences, such as suicide and impaired interpersonal relationships at work and at home.1–3 Some people may experience only a single episode in their lifetimes, but more often a person may have multiple episodes.1–3 MDD is one of the most common mental disorders in the United States, affecting 6.7% of the population annually. Women are 70% more likely to experience MDD than men.2
Disciplines
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
Keywords
antidepressant, major depressive disorder (MDD), pharmacotherapy, Vortioxetine (Brintellix)
NSUWorks Citation
D'Agostino, Mario A.; English, Clayton; and Rey, Jose A., "Vortioxetine (Brintellix): A New Serotonergic Antidepressant" (2015). Faculty Articles. 330.
https://nsuworks.nova.edu/hpd_corx_facarticles/330
